VCAM1 (Protein | Antibody | cDNA Clone | ELISA Kit)

All VCAM1 reagents are produced in house and quality controlled, including 13 VCAM1 Antibody, 2 VCAM1 ELISA, 52 VCAM1 Gene, 1 VCAM1 IP Kit, 5 VCAM1 Lysate, 5 VCAM1 Protein, 3 VCAM1 qPCR. All VCAM1 reagents are ready to use.

More Product Popular With Customers

VCAM1 Background

Vascular cell adhesion molecule 1 (VCAM-1), also known as CD16, is a cell surface sialoglycoprotein belonging to the immunoglobulin superfamily. Two forms of VCAM-1 with either six or seven extracellular Ig-like domains are generated by alternative splicing, with the longer form predominant. VCAM-1 is an endothelial ligand for very late antigen-4 (VLA-4) and α4ß7 integrin expressed on leukocytes, and thus mediates leukocyte-endothelial cell adhesion and signal transduction. VCAM-1 expression is induced on endothelial cells during inflammatory bowel disease, atherosclerosis, allograft rejection, infection, and asthmatic responses. During these responses, VCAM-1 forms a scaffold for leukocyte migration. VCAM-1 also activates signals within endothelial cells resulting in the opening of an "endothelial cell gate" through which leukocytes migrate. VCAM-1 has been identified as a potential anti-inflammatory therapeutic target, the hypothesis being that reduced expression of VCAM-1 will slow the development of atherosclerosis. In addition, VCAM-1-activated signals in endothelial cells are regulated by cytokines indicating that it is important to consider both endothelial cell adhesion molecule expression and function during inflammatory processes.

VCAM1 References

  • Cook-Mills JM. (2002) VCAM-1 signals during lymphocyte migration: role of reactive oxygen species. Mol Immunol. 39(9): 499-508.
  • Preiss DJ, et al. (2007) Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis? Int J Clin Pract. 61(4): 697-701.
彩票大奖得主捐赠 广西11选5网上投注 今天广西快3开奖情况 万州麻将换三张手机 北京十一选五基本走势 甘肃11选5软件 正规的网络赚钱方式 股票app软件 湖北快3开奖直播今天 德甲赛程500 天天海南麻将安装